Immuron Ltd IMRN

Latest FY: 2025 Healthcare Biotechnology
Market Price $1.09
Market Cap $255.02M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑48.6% YoY
$7.29M
3-Yr CAGR: 112.0%
Net Income ↑24.8% YoY
-$5.22M
Net Margin: -71.6%
Free Cash Flow ↓-58.5% YoY
N/A
FCF Yield: N/A
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
-64.6%
ROA: -51.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (IMRN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $1.0M $0.7M $-7.1M $-0.0M
FY 2017 $1.4M +39.5% $1.1M $-6.8M +3.7% 0.00% $0.0M
FY 2018 $1.8M +32.0% $1.4M $-3.0M +55.7% 0.00% $0.0M $-0.0M
FY 2019 $2.4M +29.5% $1.7M $-4.6M -53.9% 0.00% $0.0M $-0.0M +62.2%
FY 2020 $1.9M -20.5% $1.2M $-2.9M +36.8% 0.00% $-0.0M $-0.0M -811.5%
FY 2021 $0.1M -92.3% $0.1M $-8.4M -186.4% 0.00% $0.0M $0.0M +114.1%
FY 2022 $0.8M +424.9% $0.5M $-2.9M +66.0% 0.00% $0.0M $0.0M +356.0%
FY 2023 $1.8M +135.8% $1.3M $-3.8M -32.7% 0.00% $0.1M $0.1M +825.1%
FY 2024 $4.9M +171.7% $3.3M $-6.9M -83.2% 0.00% $0.3M $0.3M +201.7%
FY 2025 $7.3M +48.6% $4.8M $-5.2M +24.8% 0.00% $0.1M $0.1M -58.5%
$

Valuation

Market Price $1.09
Market Cap $255.02M
Enterprise Value $252.33M
P/E Ratio N/A
P/B Ratio 31.75
FCF Yield N/A
Dividend Yield 0.00%
Shares Outstanding 233,959,013
%

Profitability & Margins

Gross Margin 65.39%
Operating Margin -73.34%
Net Margin -71.58%
Return on Equity (ROE) -64.64%
Return on Assets (ROA) -51.49%
Asset Turnover 0.72x
Revenue 3-Yr CAGR 111.96%
🛡️

Financial Health & Liquidity

Current Ratio 5.09
Cash Ratio 1.44
Debt / Equity 0.018
Debt / Assets 0.014
Cash & Equivalents $2.83M
Total Debt $143.71K
Book Value / Share $0.03
💧

Cash Flow Efficiency

Operating Cash Flow $135.87K
Capital Expenditures (CapEx) N/A
Free Cash Flow N/A
OCF / Revenue 1.86%
FCF / Revenue N/A
FCF 3-Yr CAGR 126.21%
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $0.03
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $10.13M
Total Liabilities $2.06M
Stockholders' Equity $8.07M
Current Assets $10.02M
Current Liabilities $1.97M